Targetable genetic features of primary testicular and primary central nervous system lymphomas

Autor: Ekaterina S. Jordanova, Bjoern Chapuy, Chip Stewart, Azra H. Ligon, Liye Zhang, Andrew Dunford, Heather Homer, Gerald Illerhaus, Aaron R. Thorner, Ryan Abo, Miyuki Aono, Scott J. Rodig, Todd R. Golub, Keith L. Ligon, Yuxiang Tan, David Meredith, Margaret A. Shipp, Gad Getz, Stefano Monti, Heather Sun, Daphne de Jong, Gang Liu, Margaretha G.M. Roemer, Erica Linden, Judith A. Ferry, Geraldine S. Pinkus, Friedrich Feuerhake, Matthew D. Ducar, Paul Van Hummelen, Gordon J. Freeman, Daniel Gusenleitner
Přispěvatelé: Pathology, Obstetrics and gynaecology, CCA - Target Discovery & Preclinial Therapy Development, Other departments
Rok vydání: 2016
Předmět:
Zdroj: Blood, 127(7), 869-881. American Society of Hematology
Chapuy, B, Roemer, M G M, Stewart, C, Tan, Y, Abo, R P, Zhang, L, Dunford, A J, Meredith, D M, Thorner, A R, Jordanova, E S, Liu, G, Feuerhake, F, Ducar, M D, Illerhaus, G, Gusenleitner, D, Linden, E A, Sun, H H, Homer, H, Aono, M, Pinkus, G S, Ligon, A H, Ligon, K L, Ferry, J A, Freeman, G J, van Hummelen, P, Golub, T R, Getz, G, Rodig, S J, de Jong, D, Monti, S & Shipp, M A 2016, ' Targetable genetic features of primary testicular and primary central nervous system lymphomas ', Blood, vol. 127, no. 7, pp. 869-881 . https://doi.org/10.1182/blood-2015-10-673236
ISSN: 1528-0020
0006-4971
Popis: Primary central nervous system lymphomas (PCNSLs) and primary testicular lymphomas (PTLs) are extranodal large B-cell lymphomas (LBCLs) with inferior responses to current empiric treatment regimens. To identify targetable genetic features of PCNSL and PTL, we characterized their recurrent somatic mutations, chromosomal rearrangements, copy number alterations (CNAs), and associated driver genes, and compared these comprehensive genetic signatures to those of diffuse LBCL and primary mediastinal large B-cell lymphoma (PMBL). These studies identify unique combinations of genetic alterations in discrete LBCL subtypes and subtype-selective bases for targeted therapy. PCNSLs and PTLs frequently exhibit genomic instability, and near-uniform, often biallelic, CDKN2A loss with rare TP53 mutations. PCNSLs and PTLs also use multiple genetic mechanisms to target key genes and pathways and exhibit near-uniform oncogenic Toll-like receptor signaling as a result of MYD88 mutation and/or NFKBIZ amplification, frequent concurrent B-cell receptor pathway activation, and deregulation of BCL6. Of great interest, PCNSLs and PTLs also have frequent 9p24.1/PD-L1/PD-L2 CNAs and additional translocations of these loci, structural bases of immune evasion that are shared with PMBL.
Databáze: OpenAIRE